Qualigen Therapeutics to implement 1-for-50 reverse stock split

Qualigen Therapeutics (QLGN) announced that it will implement a 1-for-50 reverse stock split of the issued shares of its common stock, effective at 12:01 a.m. Eastern time on November 5, 2024. The Company’s common stock is expected to begin trading on a split-adjusted basis when the market opens on Tuesday, November 5, 2024, and will continue to trade on The Nasdaq Capital Market under the symbol “QLGN.”